Swiss National Bank’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-60,900
| Closed | -$513K | – | 2491 |
|
|
2024
Q2 | $513K | Sell |
60,900
-3,500
| -5% | -$37.3K | ﹤0.01% | 2417 |
|
|
2024
Q1 | $930K | Sell |
64,400
-6,800
| -10% | -$112K | ﹤0.01% | 2257 |
|
|
2023
Q4 | $1.53M | Sell |
71,200
-7,600
| -10% | -$136K | ﹤0.01% | 1998 |
|
|
2023
Q3 | $1.51M | Buy |
78,800
+1,000
| +1% | +$21.3K | ﹤0.01% | 2004 |
|
|
2023
Q2 | $1.98M | Buy |
77,800
+5,200
| +7% | +$150K | ﹤0.01% | 1891 |
|
|
2023
Q1 | $2.62M | Sell |
72,600
-8,500
| -10% | -$299K | ﹤0.01% | 1661 |
|
|
2022
Q4 | $3.21M | Buy |
81,100
+1,700
| +2% | +$70.7K | ﹤0.01% | 1586 |
|
|
2022
Q3 | $3.7M | Buy |
79,400
+900
| +1% | +$41.8K | ﹤0.01% | 1465 |
|
|
2022
Q2 | $3.44M | Hold |
78,500
| – | – | ﹤0.01% | 1552 |
|
|
2022
Q1 | $5.68M | Buy |
78,500
+5,500
| +8% | +$397K | ﹤0.01% | 1365 |
|
|
2021
Q4 | $5.92M | Hold |
73,000
| – | – | ﹤0.01% | 1350 |
|
|
2021
Q3 | $8.5M | Buy |
73,000
+500
| +0.7% | +$65.4K | 0.01% | 1088 |
|
|
2021
Q2 | $12M | Sell |
72,500
-2,300
| -3% | -$359K | 0.01% | 921 |
|
|
2021
Q1 | $10.4M | Buy |
74,800
+1,100
| +1% | +$179K | 0.01% | 983 |
|
|
2020
Q4 | $12.8M | Buy |
73,700
+500
| +0.7% | +$81K | 0.01% | 808 |
|
|
2020
Q3 | $10.2M | Buy |
73,200
+5,700
| +8% | +$762K | 0.01% | 796 |
|
|
2020
Q2 | $8.06M | Buy |
67,500
+7,400
| +12% | +$878K | 0.01% | 879 |
|
|
2020
Q1 | $6.01M | Buy |
60,100
+1,000
| +2% | +$120K | 0.01% | 836 |
|
|
2019
Q4 | $6.95M | Buy |
59,100
+1,700
| +3% | +$168K | 0.01% | 953 |
|
|
2019
Q3 | $4.93M | Buy |
57,400
+900
| +2% | +$68.1K | 0.01% | 1113 |
|
|
2019
Q2 | $3.66M | Buy |
56,500
+7,000
| +14% | +$436K | ﹤0.01% | 1316 |
|
|
2019
Q1 | $3.09M | Buy |
49,500
+1,600
| +3% | +$75.2K | ﹤0.01% | 1382 |
|
|
2018
Q4 | $1.86M | Buy |
47,900
+1,200
| +3% | +$53.3K | ﹤0.01% | 1618 |
|
|
2018
Q3 | $2.66M | Hold |
46,700
| – | – | ﹤0.01% | 1527 |
|
|
2018
Q2 | $3.73M | Buy |
46,700
+5,600
| +14% | +$465K | ﹤0.01% | 1290 |
|
|
2018
Q1 | $3.56M | Buy |
41,100
+1,000
| +2% | +$80.7K | ﹤0.01% | 1265 |
|
|
2017
Q4 | $2.77M | Buy |
40,100
+1,200
| +3% | +$96K | ﹤0.01% | 1432 |
|
|
2017
Q3 | $3.54M | Hold |
38,900
| – | – | ﹤0.01% | 1250 |
|
|
2017
Q2 | $2.9M | Buy |
38,900
+3,200
| +9% | +$256K | ﹤0.01% | 1347 |
|
|
2017
Q1 | $3.35M | Buy |
35,700
+500
| +1% | +$45.3K | ﹤0.01% | 1247 |
|
|
2016
Q4 | $2.56M | Buy |
35,200
+800
| +2% | +$68.5K | ﹤0.01% | 1397 |
|
|
2016
Q3 | $3.59M | Buy |
34,400
+700
| +2% | +$63.2K | 0.01% | 1130 |
|
|
2016
Q2 | $2.49M | Buy |
33,700
+8,200
| +32% | +$557K | ﹤0.01% | 1349 |
|
|
2016
Q1 | $1.39M | Buy |
25,500
+6,300
| +33% | +$372K | ﹤0.01% | 1693 |
|
|
2015
Q4 | $1.3M | Buy |
19,200
+800
| +4% | +$42.8K | ﹤0.01% | 1631 |
|
|
2015
Q3 | $854K | Buy |
18,400
+2,500
| +16% | +$121K | ﹤0.01% | 1864 |
|
|
2015
Q2 | $855K | Buy |
+15,900
| New | +$810K | ﹤0.01% | 1889 |
|
Other funds holding NVRO
ACH
AC
EC
B
RSCM
Swiss National Bank's NVRO Position: Q3 2024 in Review
Swiss National Bank sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 60,900 shares — an estimated $513K sold.
Swiss National Bank first reported a position in NVRO in Q2 2015 and held it in 37 quarters. The position peaked at $12.8M in Q4 2020. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.
- Swiss National Bank reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
- Swiss National Bank sold 60,900 NEVRO CORP. shares in Q3 2024, an estimated $513K.
- Swiss National Bank first reported a position in NEVRO CORP. in Q2 2015 and held it in 37 quarters.
- Swiss National Bank's NEVRO CORP. position peaked at $12.8M in Q4 2020.
- 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.